CellResearch Corporation (CRC) Announces Positive Results of Phase I Study For CorLiCyte^®

CellResearch Corporation announced it has successfully closed the first Phase I study in CorLiCyte®, a stem cell therapy derived from umbilical cord lining stem cells, with research partners at the University of Colorado, Anschutz Medical Campus and ClinImmune Cell and Gene Therapy.